Co-careldopa - Parkinson's disease (challenge test)
You are here : Home > Formulary Search > Co-careldopa - Parkinson's disease (challenge test)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (National)
PAD Profile
ChemicalSubstance :
Co-careldopa
Indication :
Parkinson's disease (challenge test)
Group Name :
Keywords :
PD, challenge test, levodopa, dopamine, carbidopa
Brand Names Include :
Sinemet, Sinemet CR, Sinemet Plus, Caramet, Half-Sinemet CR, Lecado, Duodopa, Apodespan
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Co-careldopa is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Parkinson's disease (challenge test).
Committee Recommendations (1)
NICE issued a Do Not Do Recommendation in June 2006 (updated July 2017) which states:
"Acute levodopa and apomorphine challenge tests should not be used in the differential diagnosis of parkinsonian syndromes."